Off-Label Promotion, On-Target Sales

1. HamptonT

2007

Experts weigh in on promotion, prescription of off-label drugs.

JAMA

297

683

684

2. GoldbergABGreenbergMBDarneyPD

2001

Misoprostol and pregnancy.

N Engl J Med

344

38

47

3. RadleyDCFinkelsteinSNStaffordRS

2006

Off-label prescribing among office-based physicians.

Arch Intern Med

166

1021

1026

4. General Accounting Office

2001

Drug safety: Most drugs withdrawn in recent years had greater health risks for women. GAO-01-286R.

Available: http://www.gao.gov/new.items/d01286r.pdf. Accessed 23 September 2008

5. StaffordRSRadleyDC

2003

National trends in antiobesity medication use.

Arch Intern Med

163

1046

1050

6. GazarianMKellyMMcPheeJRGraudinsLVWardRL

2006

Off-label use of medicines: Consensus recommendations for evaluating appropriateness.

Med J Aust

185

544

548

7. BresalierRSSandlerRSQuanHBologneseJAOxeniusB

2005

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

N Engl J Med

352

1092

1102

8. CinquegranaJLloydDK

2006

Legal: Shifting perspective on off-label promotion. Pharmaceutical Executive.

Available: http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=282490. Accessed 23 September 2008

9. WeeksADFialaCSafarP

2005

Misoprostol and the debate over off-label drug use.

BJOG

112

269

272

10. MuirH

2006

Medical roulette: Dicing with death.

New Sci

191

38

41

11. BaghdadiR

2007

An eye for an eye: Lucentis and the new value system for pharmaceuticals.

RPM Report

2

1

5

12. SteinmanMABeroLAChrenMMLandefeldCS

2006

Narrative review: The promotion of gabapentin: An analysis of internal industry documents.

Ann Intern Med

145

284

293

13. Committee on Finance United States Senate

2007

Use of educational grants by pharmaceutical manufacturers.

Available: http://www.acme-assn.org/home/prb042507a.pdf. Accessed 23 September 2008

14. ArnoldM

2005

Flexible forces.

Medical Marketing Media

11

40

15. NilesS

2006

A matter of trust.

Med Ad News

12

1

16. WassersteinJNPowellBF

2008

Another brick in the wall—DC enacts law regulating pharmaceutical marketing. Regulatory Focus.

Available: http://www.fdalawblog.net/fda_law_blog_hyman_phelps/files/regulatory_focus_article.pdf. Accessed 23 September 2008